ANAFRANIL DIN 00324019
Health Canada record
| Active ingredient(s) | CLOMIPRAMINE HYDROCHLORIDE 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AA04 CLOMIPRAMINE |
| Original market date | 31-Dec-1973 |
| Current status date | 12-Mar-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CLOMIPRAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00330566 | ANAFRANIL | APOTEX INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Marketed |
| 00402591 | ANAFRANIL | APOTEX INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Marketed |
| 02040751 | APO-CLOMIPRAMINE | APOTEX INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Approved |
| 02040778 | APO-CLOMIPRAMINE | APOTEX INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Approved |
| 02040786 | APO-CLOMIPRAMINE | APOTEX INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Approved |
| 02239206 | CLOMICALM | VIRBAC AH, INC. | Tablet | CLOMIPRAMINE HYDROCHLORIDE 20 MG | Marketed |
| 02239207 | CLOMICALM | VIRBAC AH, INC. | Tablet | CLOMIPRAMINE HYDROCHLORIDE 5 MG | Marketed |
| 02239205 | CLOMICALM | VIRBAC AH, INC. | Tablet | CLOMIPRAMINE HYDROCHLORIDE 80 MG | Marketed |
| 02497514 | TARO-CLOMIPRAMINE | TARO PHARMACEUTICALS INC | Capsule | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Marketed |
| 02497506 | TARO-CLOMIPRAMINE | TARO PHARMACEUTICALS INC | Capsule | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Marketed |
| 02244818 | ACT CLOMIPRAMINE | ACTAVIS PHARMA COMPANY | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02244816 | ACT CLOMIPRAMINE | ACTAVIS PHARMA COMPANY | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02244817 | ACT CLOMIPRAMINE | ACTAVIS PHARMA COMPANY | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02446774 | ALTIUS-CLOMIPRAMINE | ASPRI PHARMA CANADA INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Pre Market |
| 02446758 | ALTIUS-CLOMIPRAMINE | ASPRI PHARMA CANADA INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02446766 | ALTIUS-CLOMIPRAMINE | ASPRI PHARMA CANADA INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Pre Market |
| 02230063 | CLOMIPRAMINE TABLETS 10MG | PREMPHARM INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02230064 | CLOMIPRAMINE TABLETS 25MG | PREMPHARM INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02230065 | CLOMIPRAMINE TABLETS 50MG | PREMPHARM INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02130122 | CLOMIPRAMINE-10 - TAB 10MG | PRO DOC LIMITEE | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02130130 | CLOMIPRAMINE-25 - TAB 25MG | PRO DOC LIMITEE | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02130149 | CLOMIPRAMINE-50 - TAB 50MG | PRO DOC LIMITEE | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02231667 | DOM-CLOMIPRAMINE | DOMINION PHARMACAL | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02231669 | DOM-CLOMIPRAMINE | DOMINION PHARMACAL | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02139340 | GEN-CLOMIPRAMINE - TAB 10MG | GENPHARM ULC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02139359 | GEN-CLOMIPRAMINE - TAB 25MG | GENPHARM ULC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02139367 | GEN-CLOMIPRAMINE - TAB 50MG | GENPHARM ULC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02189003 | MED CLOMIPRAMINE TABLETS - 25MG | MEDICAN PHARMA INCORPORATED | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02189011 | MED CLOMIPRAMINE TABLETS - 50MG | MEDICAN PHARMA INCORPORATED | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02230256 | NOVO-CLOPAMINE TAB 10MG | NOVOPHARM LIMITED | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02130165 | NOVO-CLOPAMINE TABLETS - 25MG | NOVOPHARM LIMITED | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02130173 | NOVO-CLOPAMINE TABLETS- 50MG | NOVOPHARM LIMITED | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02229589 | PENTA-CLOMIPRAMINE - 25MG | PENTAPHARM LTD. | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 02229590 | PENTA-CLOMIPRAMINE - 50MG | PENTAPHARM LTD. | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02231611 | PMS-CLOMIPRAMINE | PHARMASCIENCE INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 50 MG | Cancelled Pre Market |
| 02231610 | PMS-CLOMIPRAMINE | PHARMASCIENCE INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 25 MG | Cancelled Pre Market |
| 02231608 | PMS-CLOMIPRAMINE | PHARMASCIENCE INC | Tablet | CLOMIPRAMINE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24333 | 2020-09-30 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 19638 | 2017-08-04 | New Drug Submission (NDS) | Administrative: Transfer of Drug Identification Numbers |
| 16685 | 2015-03-11 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 13403 | 2012-06-21 | New Drug Submission (NDS) | Manufacturer name change |
| 10490 | 2009-08-11 | New Drug Submission (NDS) | Manufacturer name change |
| 341 | 2002-10-15 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 3671 | 1997-05-15 | New Drug Submission (NDS) |
International API supply for CLOMIPRAMINE HYDROCHLORIDE
5 valid EDQM Certificates of Suitability from 5 holders. 7 active FDA Drug Master Files.
Request a quote for ANAFRANIL